Similar articles

• A symposium: lipid management summit on improving practice outcome. Introduction.

  Ballantyne CM. Ballantyne CM. Am J Cardiol. 2000 Feb 10;85(3A):1A-2A. doi: 10.1016/s0002-9149(99)00931-5. Am J Cardiol. 2000. PMID: 10695700 No abstract available.
• Which lipid fraction is the target and how often should this be monitored?

  Thompson G. Thompson G. Heart. 2010 Mar;96(6):413-4. doi: 10.1136/hrt.2009.177394. Heart. 2010. PMID: 20299412 No abstract available.
• The lipid hypothesis. Genetic basis.

  Glueck CJ, Kwiterovich PO Jr. Glueck CJ, et al. Arch Surg. 1978 Jan;113(1):35-41. doi: 10.1001/archsurg.1978.01370130037006. Arch Surg. 1978. PMID: 202221 No abstract available.
• Hyperlipidaemia, hypertension, and coronary heart disease.

  Goode GK, Miller JP, Heagerty AM. Goode GK, et al. Lancet. 1995 Feb 11;345(8946):362-4. doi: 10.1016/s0140-6736(95)90345-3. Lancet. 1995. PMID: 7845119 Review. No abstract available.
• Diabetic lipemia and premature coronary artery disease.

  Lawrence AM. Lawrence AM. Ann Clin Lab Sci (1971). 1972 May-Jun;2(3):233-8. Ann Clin Lab Sci (1971). 1972. PMID: 4565122 Review. No abstract available.